Cloud DX Inc.
Cloud DX Inc. (CDXFF) Stock Competitors & Peer Comparison
See (CDXFF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CDXFF | $0.09 | +12.50% | 9.7M | -1.35 | -$0.07 | N/A |
| PMCUF | $98.00 | +0.42% | 10.2B | 61.25 | $1.60 | +0.43% |
| MTHRF | $11.00 | N/A | 7.5B | 26.19 | $0.42 | +1.19% |
| MTHRY | $4.65 | -0.64% | 6.3B | 22.14 | $0.21 | +4.35% |
| PANHF | $1.40 | -9.39% | 3B | 140.00 | $0.01 | N/A |
| CMPVF | $33.66 | +11.64% | 1.7B | 58.03 | $0.58 | +1.46% |
| PIAHY | $3.00 | N/A | 1.6B | 60.00 | $0.05 | N/A |
| CMPUY | $23.00 | -7.26% | 1.2B | 38.98 | $0.59 | N/A |
| RSLBF | $24.63 | N/A | 844.2M | 34.68 | $0.71 | +1.28% |
| CRWRF | $24.20 | N/A | 840M | 44.00 | $0.55 | +1.84% |
Stock Comparison
CDXFF vs PMCUF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PMCUF has a market cap of 10.2B. Regarding current trading prices, CDXFF is priced at $0.09, while PMCUF trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PMCUF's P/E ratio is 61.25. In terms of profitability, CDXFF's ROE is +0.70%, compared to PMCUF's ROE of +0.73%. Regarding short-term risk, CDXFF and PMCUF have similar daily volatility (0.00).Check PMCUF's competition here
CDXFF vs MTHRF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MTHRF has a market cap of 7.5B. Regarding current trading prices, CDXFF is priced at $0.09, while MTHRF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MTHRF's P/E ratio is 26.19. In terms of profitability, CDXFF's ROE is +0.70%, compared to MTHRF's ROE of +0.18%. Regarding short-term risk, CDXFF and MTHRF have similar daily volatility (0.00).Check MTHRF's competition here
CDXFF vs MTHRY Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MTHRY has a market cap of 6.3B. Regarding current trading prices, CDXFF is priced at $0.09, while MTHRY trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MTHRY's P/E ratio is 22.14. In terms of profitability, CDXFF's ROE is +0.70%, compared to MTHRY's ROE of +0.13%. Regarding short-term risk, CDXFF is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MTHRY's competition here
CDXFF vs PANHF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PANHF has a market cap of 3B. Regarding current trading prices, CDXFF is priced at $0.09, while PANHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PANHF's P/E ratio is 140.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to PANHF's ROE of +0.04%. Regarding short-term risk, CDXFF and PANHF have similar daily volatility (0.00).Check PANHF's competition here
CDXFF vs CMPVF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CMPVF has a market cap of 1.7B. Regarding current trading prices, CDXFF is priced at $0.09, while CMPVF trades at $33.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CMPVF's P/E ratio is 58.03. In terms of profitability, CDXFF's ROE is +0.70%, compared to CMPVF's ROE of +0.01%. Regarding short-term risk, CDXFF is less volatile compared to CMPVF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CMPVF's competition here
CDXFF vs PIAHY Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PIAHY has a market cap of 1.6B. Regarding current trading prices, CDXFF is priced at $0.09, while PIAHY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PIAHY's P/E ratio is 60.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to PIAHY's ROE of +0.04%. Regarding short-term risk, CDXFF is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check PIAHY's competition here
CDXFF vs CMPUY Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, CDXFF is priced at $0.09, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, CDXFF's ROE is +0.70%, compared to CMPUY's ROE of +0.01%. Regarding short-term risk, CDXFF and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
CDXFF vs RSLBF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RSLBF has a market cap of 844.2M. Regarding current trading prices, CDXFF is priced at $0.09, while RSLBF trades at $24.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RSLBF's P/E ratio is 34.68. In terms of profitability, CDXFF's ROE is +0.70%, compared to RSLBF's ROE of +0.25%. Regarding short-term risk, CDXFF and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
CDXFF vs CRWRF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CRWRF has a market cap of 840M. Regarding current trading prices, CDXFF is priced at $0.09, while CRWRF trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CRWRF's P/E ratio is 44.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to CRWRF's ROE of +0.07%. Regarding short-term risk, CDXFF is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CRWRF's competition here
CDXFF vs SMSZF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SMSZF has a market cap of 702.6M. Regarding current trading prices, CDXFF is priced at $0.09, while SMSZF trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SMSZF's P/E ratio is 17.83. In terms of profitability, CDXFF's ROE is +0.70%, compared to SMSZF's ROE of +0.15%. Regarding short-term risk, CDXFF is less volatile compared to SMSZF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check SMSZF's competition here
CDXFF vs VHIBF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, VHIBF has a market cap of 374.3M. Regarding current trading prices, CDXFF is priced at $0.09, while VHIBF trades at $5.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas VHIBF's P/E ratio is 84.57. In terms of profitability, CDXFF's ROE is +0.70%, compared to VHIBF's ROE of +0.03%. Regarding short-term risk, CDXFF is less volatile compared to VHIBF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check VHIBF's competition here
CDXFF vs KSIOF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, KSIOF has a market cap of 303.6M. Regarding current trading prices, CDXFF is priced at $0.09, while KSIOF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas KSIOF's P/E ratio is -317.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to KSIOF's ROE of -0.04%. Regarding short-term risk, CDXFF and KSIOF have similar daily volatility (0.00).Check KSIOF's competition here
CDXFF vs COGZF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, COGZF has a market cap of 290.7M. Regarding current trading prices, CDXFF is priced at $0.09, while COGZF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas COGZF's P/E ratio is 28.33. In terms of profitability, CDXFF's ROE is +0.70%, compared to COGZF's ROE of +0.29%. Regarding short-term risk, CDXFF and COGZF have similar daily volatility (0.00).Check COGZF's competition here
CDXFF vs SMDCF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, CDXFF is priced at $0.09, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, CDXFF's ROE is +0.70%, compared to SMDCF's ROE of N/A. Regarding short-term risk, CDXFF and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
CDXFF vs DLHTF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, CDXFF is priced at $0.09, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, CDXFF's ROE is +0.70%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, CDXFF and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
CDXFF vs VPAHF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, CDXFF is priced at $0.09, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, CDXFF and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
CDXFF vs ACMLF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ACMLF has a market cap of 149.3M. Regarding current trading prices, CDXFF is priced at $0.09, while ACMLF trades at $4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ACMLF's P/E ratio is 43.70. In terms of profitability, CDXFF's ROE is +0.70%, compared to ACMLF's ROE of +0.20%. Regarding short-term risk, CDXFF is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check ACMLF's competition here
CDXFF vs SUSRF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SUSRF has a market cap of 144.9M. Regarding current trading prices, CDXFF is priced at $0.09, while SUSRF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SUSRF's P/E ratio is 20.29. In terms of profitability, CDXFF's ROE is +0.70%, compared to SUSRF's ROE of +0.02%. Regarding short-term risk, CDXFF is less volatile compared to SUSRF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check SUSRF's competition here
CDXFF vs ONVVF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ONVVF has a market cap of 122.8M. Regarding current trading prices, CDXFF is priced at $0.09, while ONVVF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ONVVF's P/E ratio is -8.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to ONVVF's ROE of -2.27%. Regarding short-term risk, CDXFF is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check ONVVF's competition here
CDXFF vs RVRC Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RVRC has a market cap of 101.4M. Regarding current trading prices, CDXFF is priced at $0.09, while RVRC trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RVRC's P/E ratio is -0.35. In terms of profitability, CDXFF's ROE is +0.70%, compared to RVRC's ROE of +0.07%. Regarding short-term risk, CDXFF and RVRC have similar daily volatility (0.00).Check RVRC's competition here
CDXFF vs CSAMF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, CDXFF is priced at $0.09, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, CDXFF's ROE is +0.70%, compared to CSAMF's ROE of -0.85%. Regarding short-term risk, CDXFF and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
CDXFF vs HITC Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, CDXFF is priced at $0.09, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HITC's P/E ratio is -14.75. In terms of profitability, CDXFF's ROE is +0.70%, compared to HITC's ROE of -0.79%. Regarding short-term risk, CDXFF is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check HITC's competition here
CDXFF vs MDPEF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MDPEF has a market cap of 42.6M. Regarding current trading prices, CDXFF is priced at $0.09, while MDPEF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MDPEF's P/E ratio is 0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to MDPEF's ROE of N/A. Regarding short-term risk, CDXFF and MDPEF have similar daily volatility (0.00).Check MDPEF's competition here
CDXFF vs TREIF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, TREIF has a market cap of 36.6M. Regarding current trading prices, CDXFF is priced at $0.09, while TREIF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas TREIF's P/E ratio is -3.46. In terms of profitability, CDXFF's ROE is +0.70%, compared to TREIF's ROE of -1.90%. Regarding short-term risk, CDXFF is less volatile compared to TREIF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check TREIF's competition here
CDXFF vs VASO Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, VASO has a market cap of 31.7M. Regarding current trading prices, CDXFF is priced at $0.09, while VASO trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas VASO's P/E ratio is 18.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to VASO's ROE of +0.06%. Regarding short-term risk, CDXFF is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check VASO's competition here
CDXFF vs EMOR Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EMOR has a market cap of 30.6M. Regarding current trading prices, CDXFF is priced at $0.09, while EMOR trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EMOR's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to EMOR's ROE of +0.06%. Regarding short-term risk, CDXFF is less volatile compared to EMOR. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check EMOR's competition here
CDXFF vs CRVW Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CRVW has a market cap of 23M. Regarding current trading prices, CDXFF is priced at $0.09, while CRVW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CRVW's P/E ratio is -3.94. In terms of profitability, CDXFF's ROE is +0.70%, compared to CRVW's ROE of +0.10%. Regarding short-term risk, CDXFF is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CRVW's competition here
CDXFF vs RTNXF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, CDXFF is priced at $0.09, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, CDXFF's ROE is +0.70%, compared to RTNXF's ROE of -6.31%. Regarding short-term risk, CDXFF is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check RTNXF's competition here
CDXFF vs HDSLF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, CDXFF is priced at $0.09, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, CDXFF's ROE is +0.70%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, CDXFF is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check HDSLF's competition here
CDXFF vs THKKF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, CDXFF is priced at $0.09, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas THKKF's P/E ratio is -1.51. In terms of profitability, CDXFF's ROE is +0.70%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, CDXFF and THKKF have similar daily volatility (0.00).Check THKKF's competition here
CDXFF vs DGNOF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, DGNOF has a market cap of 17M. Regarding current trading prices, CDXFF is priced at $0.09, while DGNOF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas DGNOF's P/E ratio is -4.17. In terms of profitability, CDXFF's ROE is +0.70%, compared to DGNOF's ROE of +30.80%. Regarding short-term risk, CDXFF is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check DGNOF's competition here
CDXFF vs MNNDF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, CDXFF is priced at $0.09, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, CDXFF's ROE is +0.70%, compared to MNNDF's ROE of N/A. Regarding short-term risk, CDXFF is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MNNDF's competition here
CDXFF vs PBSV Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PBSV has a market cap of 11.5M. Regarding current trading prices, CDXFF is priced at $0.09, while PBSV trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PBSV's P/E ratio is -50.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, CDXFF is less volatile compared to PBSV. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check PBSV's competition here
CDXFF vs CMHSF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CMHSF has a market cap of 10.1M. Regarding current trading prices, CDXFF is priced at $0.09, while CMHSF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CMHSF's P/E ratio is -3.73. In terms of profitability, CDXFF's ROE is +0.70%, compared to CMHSF's ROE of +0.28%. Regarding short-term risk, CDXFF is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CMHSF's competition here
CDXFF vs BRGX Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, BRGX has a market cap of 8.7M. Regarding current trading prices, CDXFF is priced at $0.09, while BRGX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas BRGX's P/E ratio is -0.90. In terms of profitability, CDXFF's ROE is +0.70%, compared to BRGX's ROE of +0.40%. Regarding short-term risk, CDXFF and BRGX have similar daily volatility (0.00).Check BRGX's competition here
CDXFF vs HBCNF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, CDXFF is priced at $0.09, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, CDXFF's ROE is +0.70%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, CDXFF is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check HBCNF's competition here
CDXFF vs SPLTF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SPLTF has a market cap of 8M. Regarding current trading prices, CDXFF is priced at $0.09, while SPLTF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SPLTF's P/E ratio is -2.60. In terms of profitability, CDXFF's ROE is +0.70%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, CDXFF is less volatile compared to SPLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check SPLTF's competition here
CDXFF vs VYND Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, VYND has a market cap of 7.9M. Regarding current trading prices, CDXFF is priced at $0.09, while VYND trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas VYND's P/E ratio is -43.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to VYND's ROE of +0.81%. Regarding short-term risk, CDXFF and VYND have similar daily volatility (0.00).Check VYND's competition here
CDXFF vs CMPD Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CMPD has a market cap of 7.7M. Regarding current trading prices, CDXFF is priced at $0.09, while CMPD trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CMPD's P/E ratio is -13.04. In terms of profitability, CDXFF's ROE is +0.70%, compared to CMPD's ROE of -0.04%. Regarding short-term risk, CDXFF and CMPD have similar daily volatility (0.00).Check CMPD's competition here
CDXFF vs WLSS Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, WLSS has a market cap of 6.9M. Regarding current trading prices, CDXFF is priced at $0.09, while WLSS trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas WLSS's P/E ratio is -249.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to WLSS's ROE of +0.33%. Regarding short-term risk, CDXFF is less volatile compared to WLSS. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check WLSS's competition here
CDXFF vs CRBKF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, CDXFF is priced at $0.09, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, CDXFF's ROE is +0.70%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, CDXFF and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
CDXFF vs DOCRF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, CDXFF is priced at $0.09, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, CDXFF's ROE is +0.70%, compared to DOCRF's ROE of -1.12%. Regarding short-term risk, CDXFF and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
CDXFF vs UDOCF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, UDOCF has a market cap of 6M. Regarding current trading prices, CDXFF is priced at $0.09, while UDOCF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas UDOCF's P/E ratio is -2.30. In terms of profitability, CDXFF's ROE is +0.70%, compared to UDOCF's ROE of +62.04%. Regarding short-term risk, CDXFF and UDOCF have similar daily volatility (0.00).Check UDOCF's competition here
CDXFF vs IQAIF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, IQAIF has a market cap of 4.9M. Regarding current trading prices, CDXFF is priced at $0.09, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas IQAIF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to IQAIF's ROE of -0.17%. Regarding short-term risk, CDXFF is less volatile compared to IQAIF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check IQAIF's competition here
CDXFF vs AIMLF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, AIMLF has a market cap of 4.7M. Regarding current trading prices, CDXFF is priced at $0.09, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas AIMLF's P/E ratio is -1.39. In terms of profitability, CDXFF's ROE is +0.70%, compared to AIMLF's ROE of -5.05%. Regarding short-term risk, CDXFF is less volatile compared to AIMLF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check AIMLF's competition here
CDXFF vs CBDS Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, CDXFF is priced at $0.09, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CBDS's P/E ratio is -1.49. In terms of profitability, CDXFF's ROE is +0.70%, compared to CBDS's ROE of +0.68%. Regarding short-term risk, CDXFF is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CBDS's competition here
CDXFF vs NDATF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, NDATF has a market cap of 3.1M. Regarding current trading prices, CDXFF is priced at $0.09, while NDATF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas NDATF's P/E ratio is -7.54. In terms of profitability, CDXFF's ROE is +0.70%, compared to NDATF's ROE of -0.64%. Regarding short-term risk, CDXFF and NDATF have similar daily volatility (0.00).Check NDATF's competition here
CDXFF vs RQHTF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RQHTF has a market cap of 2.6M. Regarding current trading prices, CDXFF is priced at $0.09, while RQHTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RQHTF's P/E ratio is -0.07. In terms of profitability, CDXFF's ROE is +0.70%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, CDXFF and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
CDXFF vs RYAHF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RYAHF has a market cap of 2.2M. Regarding current trading prices, CDXFF is priced at $0.09, while RYAHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RYAHF's P/E ratio is 0.25. In terms of profitability, CDXFF's ROE is +0.70%, compared to RYAHF's ROE of +14.95%. Regarding short-term risk, CDXFF and RYAHF have similar daily volatility (0.00).Check RYAHF's competition here
CDXFF vs EBYH Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EBYH has a market cap of 1.9M. Regarding current trading prices, CDXFF is priced at $0.09, while EBYH trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EBYH's P/E ratio is -5.42. In terms of profitability, CDXFF's ROE is +0.70%, compared to EBYH's ROE of +0.14%. Regarding short-term risk, CDXFF is less volatile compared to EBYH. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check EBYH's competition here
CDXFF vs MDBIF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MDBIF has a market cap of 1.6M. Regarding current trading prices, CDXFF is priced at $0.09, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MDBIF's P/E ratio is -0.25. In terms of profitability, CDXFF's ROE is +0.70%, compared to MDBIF's ROE of -0.12%. Regarding short-term risk, CDXFF is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MDBIF's competition here
CDXFF vs RSLT Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, RSLT has a market cap of 1.5M. Regarding current trading prices, CDXFF is priced at $0.09, while RSLT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas RSLT's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to RSLT's ROE of N/A. Regarding short-term risk, CDXFF and RSLT have similar daily volatility (0.00).Check RSLT's competition here
CDXFF vs CSOC Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CSOC has a market cap of 1.4M. Regarding current trading prices, CDXFF is priced at $0.09, while CSOC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CSOC's P/E ratio is 0.25. In terms of profitability, CDXFF's ROE is +0.70%, compared to CSOC's ROE of -4.64%. Regarding short-term risk, CDXFF is less volatile compared to CSOC. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CSOC's competition here
CDXFF vs MDXL Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MDXL has a market cap of 1.2M. Regarding current trading prices, CDXFF is priced at $0.09, while MDXL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MDXL's P/E ratio is -0.28. In terms of profitability, CDXFF's ROE is +0.70%, compared to MDXL's ROE of +0.90%. Regarding short-term risk, CDXFF is less volatile compared to MDXL. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MDXL's competition here
CDXFF vs EKGGF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EKGGF has a market cap of 908.9K. Regarding current trading prices, CDXFF is priced at $0.09, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EKGGF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to EKGGF's ROE of +1.04%. Regarding short-term risk, CDXFF is less volatile compared to EKGGF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check EKGGF's competition here
CDXFF vs MITI Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MITI has a market cap of 843.2K. Regarding current trading prices, CDXFF is priced at $0.09, while MITI trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MITI's P/E ratio is -0.57. In terms of profitability, CDXFF's ROE is +0.70%, compared to MITI's ROE of -0.02%. Regarding short-term risk, CDXFF is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MITI's competition here
CDXFF vs MDRM Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MDRM has a market cap of 765.3K. Regarding current trading prices, CDXFF is priced at $0.09, while MDRM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MDRM's P/E ratio is -0.60. In terms of profitability, CDXFF's ROE is +0.70%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, CDXFF is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MDRM's competition here
CDXFF vs MDNWF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, CDXFF is priced at $0.09, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, CDXFF's ROE is +0.70%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, CDXFF is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check MDNWF's competition here
CDXFF vs EVAHF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EVAHF has a market cap of 499.5K. Regarding current trading prices, CDXFF is priced at $0.09, while EVAHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EVAHF's P/E ratio is -0.20. In terms of profitability, CDXFF's ROE is +0.70%, compared to EVAHF's ROE of +0.78%. Regarding short-term risk, CDXFF and EVAHF have similar daily volatility (0.00).Check EVAHF's competition here
CDXFF vs USPS Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, USPS has a market cap of 452.9K. Regarding current trading prices, CDXFF is priced at $0.09, while USPS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas USPS's P/E ratio is -2.86. In terms of profitability, CDXFF's ROE is +0.70%, compared to USPS's ROE of +0.62%. Regarding short-term risk, CDXFF is less volatile compared to USPS. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check USPS's competition here
CDXFF vs PPJE Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PPJE has a market cap of 445.2K. Regarding current trading prices, CDXFF is priced at $0.09, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PPJE's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to PPJE's ROE of -0.00%. Regarding short-term risk, CDXFF is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check PPJE's competition here
CDXFF vs CTVEF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CTVEF has a market cap of 418.1K. Regarding current trading prices, CDXFF is priced at $0.09, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, CDXFF's ROE is +0.70%, compared to CTVEF's ROE of +0.17%. Regarding short-term risk, CDXFF is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CTVEF's competition here
CDXFF vs DTRK Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, DTRK has a market cap of 396.2K. Regarding current trading prices, CDXFF is priced at $0.09, while DTRK trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas DTRK's P/E ratio is -3.87. In terms of profitability, CDXFF's ROE is +0.70%, compared to DTRK's ROE of +3.54%. Regarding short-term risk, CDXFF and DTRK have similar daily volatility (0.00).Check DTRK's competition here
CDXFF vs LVCE Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, LVCE has a market cap of 381.9K. Regarding current trading prices, CDXFF is priced at $0.09, while LVCE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas LVCE's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to LVCE's ROE of N/A. Regarding short-term risk, CDXFF is less volatile compared to LVCE. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check LVCE's competition here
CDXFF vs ACHKF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, CDXFF is priced at $0.09, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, CDXFF's ROE is +0.70%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, CDXFF and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
CDXFF vs NHIQ Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, CDXFF is priced at $0.09, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas NHIQ's P/E ratio is -0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, CDXFF is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check NHIQ's competition here
CDXFF vs EWLL Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EWLL has a market cap of 185.1K. Regarding current trading prices, CDXFF is priced at $0.09, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EWLL's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to EWLL's ROE of +0.13%. Regarding short-term risk, CDXFF is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check EWLL's competition here
CDXFF vs ALDNF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, CDXFF is priced at $0.09, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ALDNF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to ALDNF's ROE of +0.55%. Regarding short-term risk, CDXFF and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
CDXFF vs TSTTF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, TSTTF has a market cap of 145.8K. Regarding current trading prices, CDXFF is priced at $0.09, while TSTTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas TSTTF's P/E ratio is -0.73. In terms of profitability, CDXFF's ROE is +0.70%, compared to TSTTF's ROE of -0.02%. Regarding short-term risk, CDXFF is less volatile compared to TSTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check TSTTF's competition here
CDXFF vs EMYSF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, EMYSF has a market cap of 142.2K. Regarding current trading prices, CDXFF is priced at $0.09, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas EMYSF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to EMYSF's ROE of +2.20%. Regarding short-term risk, CDXFF is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check EMYSF's competition here
CDXFF vs ORHB Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ORHB has a market cap of 137.5K. Regarding current trading prices, CDXFF is priced at $0.09, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ORHB's P/E ratio is -0.10. In terms of profitability, CDXFF's ROE is +0.70%, compared to ORHB's ROE of +1.70%. Regarding short-term risk, CDXFF is less volatile compared to ORHB. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check ORHB's competition here
CDXFF vs DSOL Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, DSOL has a market cap of 88.9K. Regarding current trading prices, CDXFF is priced at $0.09, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas DSOL's P/E ratio is -0.01. In terms of profitability, CDXFF's ROE is +0.70%, compared to DSOL's ROE of +0.03%. Regarding short-term risk, CDXFF is less volatile compared to DSOL. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check DSOL's competition here
CDXFF vs NEWUF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, NEWUF has a market cap of 86.6K. Regarding current trading prices, CDXFF is priced at $0.09, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas NEWUF's P/E ratio is -0.02. In terms of profitability, CDXFF's ROE is +0.70%, compared to NEWUF's ROE of +0.88%. Regarding short-term risk, CDXFF and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
CDXFF vs PASO Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, CDXFF is priced at $0.09, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PASO's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to PASO's ROE of +6.20%. Regarding short-term risk, CDXFF and PASO have similar daily volatility (0.00).Check PASO's competition here
CDXFF vs LFCOF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, LFCOF has a market cap of 63.4K. Regarding current trading prices, CDXFF is priced at $0.09, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas LFCOF's P/E ratio is -0.04. In terms of profitability, CDXFF's ROE is +0.70%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, CDXFF is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check LFCOF's competition here
CDXFF vs REFG Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, CDXFF is priced at $0.09, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas REFG's P/E ratio is -0.01. In terms of profitability, CDXFF's ROE is +0.70%, compared to REFG's ROE of +0.01%. Regarding short-term risk, CDXFF and REFG have similar daily volatility (0.00).Check REFG's competition here
CDXFF vs SOFE Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SOFE has a market cap of 45.1K. Regarding current trading prices, CDXFF is priced at $0.09, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SOFE's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, CDXFF and SOFE have similar daily volatility (0.00).Check SOFE's competition here
CDXFF vs HDVY Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, CDXFF is priced at $0.09, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HDVY's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to HDVY's ROE of +15.89%. Regarding short-term risk, CDXFF and HDVY have similar daily volatility (0.00).Check HDVY's competition here
CDXFF vs IGRW Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, CDXFF is priced at $0.09, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas IGRW's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to IGRW's ROE of -2.28%. Regarding short-term risk, CDXFF is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check IGRW's competition here
CDXFF vs WMGR Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, CDXFF is priced at $0.09, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas WMGR's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to WMGR's ROE of +0.53%. Regarding short-term risk, CDXFF and WMGR have similar daily volatility (0.00).Check WMGR's competition here
CDXFF vs SSYNF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, CDXFF is priced at $0.09, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to SSYNF's ROE of N/A. Regarding short-term risk, CDXFF and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
CDXFF vs TTBLF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, CDXFF is priced at $0.09, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, CDXFF is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check TTBLF's competition here
CDXFF vs NMXS Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, NMXS has a market cap of 26.4K. Regarding current trading prices, CDXFF is priced at $0.09, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas NMXS's P/E ratio is -0.07. In terms of profitability, CDXFF's ROE is +0.70%, compared to NMXS's ROE of -2.50%. Regarding short-term risk, CDXFF is less volatile compared to NMXS. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check NMXS's competition here
CDXFF vs FDBH Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, FDBH has a market cap of 25K. Regarding current trading prices, CDXFF is priced at $0.09, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas FDBH's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, CDXFF is less volatile compared to FDBH. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check FDBH's competition here
CDXFF vs NHEL Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, CDXFF is priced at $0.09, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas NHEL's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to NHEL's ROE of +7.36%. Regarding short-term risk, CDXFF and NHEL have similar daily volatility (0.00).Check NHEL's competition here
CDXFF vs BNVIF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, BNVIF has a market cap of 13.3K. Regarding current trading prices, CDXFF is priced at $0.09, while BNVIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas BNVIF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, CDXFF is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check BNVIF's competition here
CDXFF vs HLTT Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HLTT has a market cap of 10.7K. Regarding current trading prices, CDXFF is priced at $0.09, while HLTT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HLTT's P/E ratio is -0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to HLTT's ROE of +1789941.38%. Regarding short-term risk, CDXFF and HLTT have similar daily volatility (0.00).Check HLTT's competition here
CDXFF vs CGNSF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CGNSF has a market cap of 9K. Regarding current trading prices, CDXFF is priced at $0.09, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CGNSF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, CDXFF is less volatile compared to CGNSF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CGNSF's competition here
CDXFF vs MOSTQ Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, CDXFF is priced at $0.09, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, CDXFF's ROE is +0.70%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, CDXFF and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
CDXFF vs ACNV Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, CDXFF is priced at $0.09, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ACNV's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to ACNV's ROE of +0.85%. Regarding short-term risk, CDXFF and ACNV have similar daily volatility (0.00).Check ACNV's competition here
CDXFF vs AHGIF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, AHGIF has a market cap of 7.8K. Regarding current trading prices, CDXFF is priced at $0.09, while AHGIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas AHGIF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, CDXFF is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check AHGIF's competition here
CDXFF vs BBLNF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, CDXFF is priced at $0.09, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas BBLNF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, CDXFF and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
CDXFF vs ICCO Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ICCO has a market cap of 2K. Regarding current trading prices, CDXFF is priced at $0.09, while ICCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ICCO's P/E ratio is -0.01. In terms of profitability, CDXFF's ROE is +0.70%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, CDXFF is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check ICCO's competition here
CDXFF vs HSCHF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, HSCHF has a market cap of 1.2K. Regarding current trading prices, CDXFF is priced at $0.09, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas HSCHF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to HSCHF's ROE of +1.98%. Regarding short-term risk, CDXFF and HSCHF have similar daily volatility (0.00).Check HSCHF's competition here
CDXFF vs PCYS Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, PCYS has a market cap of 1.1K. Regarding current trading prices, CDXFF is priced at $0.09, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas PCYS's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, CDXFF is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check PCYS's competition here
CDXFF vs CNONF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, CNONF has a market cap of 1.1K. Regarding current trading prices, CDXFF is priced at $0.09, while CNONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas CNONF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, CDXFF is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check CNONF's competition here
CDXFF vs OLMM Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, OLMM has a market cap of 1K. Regarding current trading prices, CDXFF is priced at $0.09, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas OLMM's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to OLMM's ROE of +4.54%. Regarding short-term risk, CDXFF is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check OLMM's competition here
CDXFF vs ETAOF Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, ETAOF has a market cap of 512. Regarding current trading prices, CDXFF is priced at $0.09, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas ETAOF's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, CDXFF is less volatile compared to ETAOF. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check ETAOF's competition here
CDXFF vs LGBI Comparison April 2026
CDXFF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDXFF stands at 9.7M. In comparison, LGBI has a market cap of 50. Regarding current trading prices, CDXFF is priced at $0.09, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDXFF currently has a P/E ratio of -1.35, whereas LGBI's P/E ratio is N/A. In terms of profitability, CDXFF's ROE is +0.70%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, CDXFF is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for CDXFF.Check LGBI's competition here